Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis

Transfusion

Volumn 57, Issue 3, 2017, Pages 661-673

  Qadri, Syed M ^a   Chen, Deborah ^b   Schubert, Peter ^b   Perruzza, Darian L ^a   Bhakta, Varsha ^a   Devine, Dana V ^b   Sheffield, William P ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; ADENOSINE TRIPHOSPHATE; CALCIUM ION; CD47 ANTIGEN; CERAMIDE; HEMOGLOBIN; IONOMYCIN; MEMBRANE PHOSPHOLIPID; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE C; RIBOFLAVIN;

ARTICLE; BLOOD BANK; BLOOD BIOCHEMISTRY; CONTROLLED STUDY; ENZYME ACTIVATION; ERYPTOSIS; ERYTHROCYTE PRESERVATION; ERYTHROCYTE VOLUME; FLOW CYTOMETRY; GENE EXPRESSION; ILLUMINATION; IN VITRO STUDY; MEMBRANE MICROPARTICLE; OSMOTIC FRAGILITY; OXIDATIVE STRESS; PATHOGEN REDUCTION SYSTEM; PATHOGENESIS; PROTEIN DEPLETION; ULTRAVIOLET RADIATION; ADVERSE EFFECTS; BLOOD STORAGE; DISINFECTION; DRUG EFFECTS; ERYTHROCYTE; FEMALE; HUMAN; MALE; METABOLISM; PATHOLOGY; RADIATION RESPONSE; TIME FACTOR;

BLOOD PRESERVATION; DISINFECTION; ERYPTOSIS; ERYTHROCYTES; FEMALE; HUMANS; MALE; RIBOFLAVIN; TIME FACTORS; ULTRAVIOLET RAYS;

EID: 85007240045     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13959     Document Type: Article

References (59)

1. de Sousa G, Seghatchian J. Highlights of PBTI Coimbra conference on PRT of plasma & current opinions on pathogen reduction treatment of blood components. Transfus Apher Sci 2015;52:228-32.
2. Seghatchian J, de Sousa G. Pathogen-reduction systems for blood components: the current position and future trends. Transfus Apher Sci 2006;35:189-96.
3. Seghatchian J, Hervig T, Putter JS. Effect of pathogen inactivation on the storage lesion in red cells and platelet concentrates. Transfus Apher Sci 2011;45:75-84.
4. Kleinman S, Stassinopoulos A. Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation. Transfusion 2015;55:2983-3000.
5. Mundt JM, Rouse L, Van den Bossche J, et al. Chemical and biological mechanisms of pathogen reduction technologies. Photochem Photobiol 2014;90:957-64.
6. Seltsam A, Müller TH. Update on the use of pathogen-reduced human plasma and platelet concentrates. Br J Haematol 2013;162:442-54.
7. Fast LD, Nevola M, Tavares J, et al. Treatment of whole blood with riboflavin plus ultraviolet light, an alternative to gamma irradiation in the prevention of transfusion-associated graft-versus-host disease? Transfusion 2013;53:373-81.
8. Antonelou MH, Kriebardis AG, Papassideri IS. Aging and death signalling in mature red cells: from basic science to transfusion practice. Blood Transfus 2010;8Suppl3:s39-47.
9. L'Acqua C, Bandyopadhyay S, Francis RO, et al. Red blood cell transfusion is associated with increased hemolysis and an acute phase response in a subset of critically ill children. Am J Hematol 2015;90:915-20.
10. Hod EA, Brittenham GM, Billote GB, et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011;118:6675-82.
11. Hod EA, Spitalnik SL. Stored red blood cell transfusions: iron, inflammation, immunity, and infection. Transfus Clin Biol 2012;19:84-9.
12. Almizraq R, Tchir JD, Holovati JL, et al. Storage of red blood cells affects membrane composition, microvesiculation, and in vitro quality. Transfusion 2013;53:2258-67.
13. da SilveiraCavalcante L, Acker JP, Holovati JL. Differences in rat and human erythrocytes following blood component manufacturing: the effect of additive solutions. Transfus Med Hemother 2015;42:150-7.
14. Hess JR. Measures of stored red blood cell quality. Vox Sang 2014;107:1-9.
15. Bosman GJ, Cluitmans JC, Groenen YA, et al. Susceptibility to hyperosmotic stress-induced phosphatidylserine exposure increases during red blood cell storage. Transfusion 2011;51:1072-8.
16. Lu C, Shi J, Yu H, et al. Procoagulant activity of long-term stored red blood cells due to phosphatidylserine exposure. Transfus Med 2011;21:150-7.
17. Zecher D, Cumpelik A, Schifferli JA. Erythrocyte-derived microvesicles amplify systemic inflammation by thrombin-dependent activation of complement. Arterioscler Thromb Vasc Biol 2014;34:313-20.
18. Hod EA, Spitalnik SL. Harmful effects of transfusion of older stored red blood cells: iron and inflammation. Transfusion 2011;51:881-5.
19. Hoehn RS, Jernigan PL, Japtok L, et al. Acid sphingomyelinase inhibition in stored erythrocytes reduces transfusion-associated lung inflammation. Ann Surg 2016 [Epub ahead of print]
20. Lang E, Qadri SM, Lang F. Killing me softly—suicidal erythrocyte death. Int J Biochem Cell Biol 2012;44:1236-43.
21. Lang F, Qadri SM. Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif 2012;33:125-30.
22. Lang E, Bissinger R, Gulbins E, et al. Ceramide in the regulation of eryptosis, the suicidal erythrocyte death. Apoptosis 2015;20:758-67.
23. Gilson CR, Kraus TS, Hod EA, et al. A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion 2009;49:1546-53.
24. Harboe M. A method for determination of hemoglobin in plasma by near-ultraviolet spectrophotometry. Scand J Clin Lab Invest 1959;11:66-70.
25. Bissinger R, Lang E, Ghashghaeinia M, et al. Blunted apoptosis of erythrocytes in mice deficient in the heterotrimeric G-protein subunit Gαi2. Sci Rep 2016;6:30925.
26. de Korte D, Kleine M, Korsten HG, et al. Prolonged maintenance of 2,3-diphosphoglycerate acid and adenosine triphosphate in red blood cells during storage. Transfusion 2008;48:1081-9.
27. Crescentini G, Stocchi V. Fast reversed-phase high-performance liquid chromatographic determination of nucleotides in red blood cells. J Chromatogr 1984;290:393-9.
28. Klarl BA, Lang PA, Kempe DS, et al. Protein kinase C mediates erythrocyte “programmed cell death” following glucose depletion. Am J Physiol Cell Physiol 2006;290:C244-53.
29. Qadri SM, Donkor DA, Bhakta V, et al. Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas aeruginosa virulence factor pyocyanin. J Cell Mol Med 2016;20:710-20.
30. Lutz HU, Bogdanova A. Mechanisms tagging senescent red blood cells for clearance in healthy humans. Front Physiol 2013;4:387.
31. Duranton C, Huber SM, Lang F. Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J Physiol 2002;539:847-55.
32. Gatidis S, Zelenak C, Fajol A, et al. p38 MAPK activation and function following osmotic shock of erythrocytes. Cell Physiol Biochem 2011;28:1279-86.
33. Hess JR. Scientific problems in the regulation of red blood cell products. Transfusion 2012;52:1827-35.
34. Schubert P, Culibrk B, Karwal S, et al. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method. Transfusion 2015;55:815-23.
35. Cancelas JA, Rugg N, Fletcher D, et al. In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood. Transfusion 2011;51:1460-8.
36. Okoye OT, Reddy H, Wong MD, et al. Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model. Transfusion 2015;55:532-43.
37. Goodrich RP, Murthy KK, Doane SK, et al. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons. Transfusion 2009;49:64-74.
38. Tormey CA, Santhanakrishnan M, Smith NH, et al. Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells. Transfusion 2015;56:863-72.
39. Qadri SM, Mahmud H, Lang E, et al. Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med 2012;16:1085-93.
40. Lang E, Bissinger R, Fajol A, et al. Accelerated apoptotic death and in vivo turnover of erythrocytes in mice lacking functional mitogen- and stress-activated kinase MSK1/2. Sci Rep 2015;5:17316.
41. Koshkaryev A, Zelig O, Manny N, et al. Rejuvenation treatment of stored red blood cells reverses storage-induced adhesion to vascular endothelial cells. Transfusion 2009;49:2136-43.
42. Kucherenko YV, Bernhardt I. Natural antioxidants improve red blood cell “survival” in non-leukoreduced blood samples. Cell Physiol Biochem 2015;35:2055-68.
43. Larsson A, Hult A, Nilsson A, et al. Red blood cells with elevated cytoplasmic Ca(2+) are primarily taken up by splenic marginal zone macrophages and CD207+ dendritic cells. Transfusion 2016;56:1834-44.
44. Lang E, Pozdeev VI, Xu HC, et al. Storage of erythrocytes induces suicidal erythrocyte death. Cell Physiol Biochem 2016;39:668-76.
45. Mandal D, Baudin-Creuza V, Bhattacharyya A, et al. Caspase 3-mediated proteolysis of the N-terminal cytoplasmic domain of the human erythroid anion exchanger 1 (band 3). J Biol Chem 2003;278:52551-8.
46. Mandal D, Moitra PK, Saha S, et al. Caspase 3 regulates phosphatidylserine externalization and phagocytosis of oxidatively stressed erythrocytes. FEBS Lett 2002;513:184-8.
47. Berg CP, Engels IH, Rothbart A, et al. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ 2001;8:1197-206.
48. Dinkla S, Wessels K, Verdurmen WP, et al. Functional consequences of sphingomyelinase-induced changes in erythrocyte membrane structure. Cell Death Dis 2012;3:e410.
49. Hoehn RS, Jernigan PL, Chang AL, et al. Acid sphingomyelinase inhibition prevents hemolysis during erythrocyte storage. Cell Physiol Biochem 2016;39:331-40.
50. Kuypers FA, de Jong K. The role of phosphatidylserine in recognition and removal of erythrocytes. Cell Mol Biol (Noisy-le-grand) 2004;50:147-58.
51. Verhoeven AJ, Hilarius PM, Dekkers DW, et al. Prolonged storage of red blood cells affects aminophospholipid translocase activity. Vox Sang 2006;91:244-51.
52. Lang E, Gatidis S, Freise NF, et al. Conjugated bilirubin triggers anemia by inducing erythrocyte death. Hepatology 2015;61:275-84.
53. Lupescu A, Bissinger R, Goebel T, et al. Enhanced suicidal erythrocyte death contributing to anemia in the elderly. Cell Physiol Biochem 2015;36:773-83.
54. Nguyen DB, Thuy Ly TB, Wesseling MC, et al. Characterization of microvesicles released from human red blood cells. Cell Physiol Biochem 2016;38:1085-99.
55. Zelenak C, Foller M, Velic A, et al. Proteome analysis of erythrocytes lacking AMP-activated protein kinase reveals a role of PAK2 kinase in eryptosis. J Proteome Res 2011;10:1690-7.
56. Zelenak C, Eberhard M, Jilani K, et al. Protein kinase CK1α regulates erythrocyte survival. Cell Physiol Biochem 2012;29:171-80.
57. Lang E, Zelenak C, Eberhard M, et al. Impact of cyclin-dependent kinase CDK4 inhibition on eryptosis. Cell Physiol Biochem 2015;37:1178-86.
58. Chen Z, Schubert P, Culibrk B, et al. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment. Transfusion 2015;55:848-57.
59. Schubert P, Coupland D, Culibrk B, et al. Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment. Transfusion 2013;53:3164-73.